Linda S. Steelman

Publications by Year

Research Areas

PI3K/AKT/mTOR signaling in cancer, Melanoma and MAPK Pathways, Cytokine Signaling Pathways and Interactions, Cancer-related Molecular Pathways, Synthesis and biological activity

Most-Cited Works

• → Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance(2006)2,275 cited
• → Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy(2003)1,188 cited
• → Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention(2003)732 cited
• → Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging(2011)695 cited
• → JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis(2004)685 cited
• → Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance(2006)661 cited
• → Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health(2011)575 cited
• → GSK-3 as potential target for therapeutic intervention in cancer(2014)493 cited
• → Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia(2008)395 cited
• Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review).(2003)